Patents Assigned to DUALITY BIOLOGICS (SUZHOU) CO., LTD.
  • ANTI-B7H3 ANTIBODY-DRUG CONJUGATE AND USE THEREOF
    Publication number: 20240148892
    Abstract: The present invention provides an antibody-drug conjugate specifically binding to B7H3 and a pharmaceutical composition comprising the same. A method for using the antibody-drug conjugate of the present invention and use thereof are also provided herein.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 9, 2024
    Applicant: Duality Biologics (Suzhou) Co., Ltd.
    Inventors: Zhongyuan ZHU, Chen ZHONG, Yu ZHANG, Chenggang LI
  • Anti-tumor compound and preparation method and use thereof
    Patent number: 11952384
    Abstract: The present application relates to an anti-tumor compound and a preparation method and use thereof, and in particular to a compound or a tautomer, a mesomer, a racemate, an enantiomer or a diastereoisomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof, and a preparation method and use thereof.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: April 9, 2024
    Assignee: DUALITY BIOLOGICS (SUZHOU) CO., LTD.
    Inventors: Yu Zhang, Zhongyuan Zhu, Haiqing Hua, Bing Li, Jian Li, Shengchao Lin, Xi Li, Hongxia Shen
  • Anti-tumor compound and preparation method and use thereof
    Patent number: 11685742
    Abstract: The present application relates to an anti-tumor compound and a preparation method and use thereof, and in particular to a compound or a tautomer, a mesomer, a racemate, an enantiomer or a diastereoisomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof, and a preparation method and use thereof.
    Type: Grant
    Filed: May 26, 2022
    Date of Patent: June 27, 2023
    Assignee: DUALITY BIOLOGICS (SUZHOU) CO., LTD.
    Inventors: Yu Zhang, Zhongyuan Zhu, Haiqing Hua, Bing Li, Jian Li, Shengchao Lin, Xi Li, Hongxia Shen
  • Anti-tumor compound and preparation method and use thereof
    Patent number: 11607459
    Abstract: The present application relates to an anti-tumor compound and a preparation method and use thereof, and in particular to a compound or a tautomer, a mesomer, a racemate, an enantiomer or a diastereoisomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof, and a preparation method and use thereof.
    Type: Grant
    Filed: May 31, 2022
    Date of Patent: March 21, 2023
    Assignee: DUALITY BIOLOGICS (SUZHOU) CO., LTD.
    Inventors: Yu Zhang, Zhongyuan Zhu, Haiqing Hua, Bing Li, Jian Li, Shengchao Lin, Xi Li, Hongxia Shen